Literature DB >> 11793995

Ellagic acid inhibits nucleoside diphosphate kinase-B activity.

N A Malmquist1, J J Anzinger, D Hirzel, I L Buxton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11793995

Source DB:  PubMed          Journal:  Proc West Pharmacol Soc        ISSN: 0083-8969


× No keyword cloud information.
  7 in total

Review 1.  Purinergic mechanisms in breast cancer support intravasation, extravasation and angiogenesis.

Authors:  Iain L O Buxton; Nucharee Yokdang; Robert M Matz
Journal:  Cancer Lett       Date:  2010-05-28       Impact factor: 8.679

Review 2.  Regulation of heterotrimeric G-protein signaling by NDPK/NME proteins and caveolins: an update.

Authors:  Issam H Abu-Taha; Jordi Heijman; Yuxi Feng; Christiane Vettel; Dobromir Dobrev; Thomas Wieland
Journal:  Lab Invest       Date:  2017-10-16       Impact factor: 5.662

3.  Measurement of human breast tumor cell-secreted shNDPK-B in a murine breast cancer model suggests its role in metastatic progression.

Authors:  Nucharee Yokdang; Noah D Buxton; Iain L O Buxton
Journal:  Proc West Pharmacol Soc       Date:  2009

Review 4.  Physiological and pathological relevance of extracellular NM23/NDP kinases.

Authors:  Junko Okabe-Kado; Takashi Kasukabe
Journal:  J Bioenerg Biomembr       Date:  2003-02       Impact factor: 2.945

5.  Blockade of extracellular NM23 or its endothelial target slows breast cancer growth and metastasis.

Authors:  Nucharee Yokdang; Senny Nordmeier; Katie Speirs; Heather R Burkin; Iain L O Buxton
Journal:  Integr Cancer Sci Ther       Date:  2015

Review 6.  Arylfluorosulfate-Based Electrophiles for Covalent Protein Labeling: A New Addition to the Arsenal.

Authors:  Pablo Martín-Gago; Christian A Olsen
Journal:  Angew Chem Int Ed Engl       Date:  2018-10-26       Impact factor: 15.336

7.  Purinergic regulation of angiogenesis by human breast carcinoma-secreted nucleoside diphosphate kinase.

Authors:  S M Rumjahn; M A Javed; N Wong; W E Law; I L O Buxton
Journal:  Br J Cancer       Date:  2007-10-16       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.